AIM Tech
SLG

AIM Tech is a medical technology company whose first product, NeoVent, is a no power, easy-to-use respiratory therapy device designed for premature newborns.

Severe respiratory illnesses in newborns result in over 1 million annual deaths, 99% of which are in low to middle income countries.

AIM Tech is a medical technology company whose first product, NeoVent, is a no power, easy-to-use respiratory therapy device designed for premature newborns. NeoVent provides noninvasive pressure ventilation at 1/100th the cost of current ventilators. Building on preclinical studies demonstrating device efficacy, AIM Tech will soon launch the first NeoVent clinical pilot in Nepal.

Every year, more than one million babies die of respiratory illness — 99% of these deaths occur in low-middle income countries. AIM Tech has developed an affordable, high quality, low-tech pressure ventilator. The patent-pending, award-winning NeoVent costs less than 1/100th┬áthe price of existing ventilators, is easy to use and requires no electrical power. NeoVent is already approved for clinical testing with plans to implement the device around the world to save millions of infant lives. AIM Tech seeks to improve health care options for underserved groups on a global scale through the development of safe, user-friendly, low power, and affordable equipment.

Zell Lurie Institute Dare to Dream grant, Michigan Business Challenge, and advising; Center for Social Impact; Center for Entrepreneurship JumpStart grants, The Startup competition, and advising; Fast Forward Medical Innovation; Medical School Pathways of Excellence in Innovation and Entrepreneurship; Zell Entrepreneurship and Law Clinic


Team: